Sign Up Today and Learn More About Medable Stock
Invest in or calculate the value of your shares in Medable or other pre-IPO companies through EquityZen's platform.
Medable Stock (MEDB)
Medable is transforming clinical research and predictive medicine by creating a platform powered by patient generated data.
About Medable Stock
Founded
2015
Headquarters
Palo Alto, CA, US
Industries
Travel and Tourism, Space, Manufacturing
Medable provides a global decentralized trial platform that streamlines design, recruitment, retention, and data quality, replacing siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. It is now used by leading biopharma sponsors and clinical research organizations worldwide and has been used for trials in 30+ countries and 26 languages. It was founded in 2015 and is headquartered in Palo Alto, California.
Medable Press Mentions
Stay in the know about the latest news on Medable
Decentralized Clinical Trials Market Projected to Reach $16.68 Billion with 17.5% CAGR by 2029
einpresswire ⢠Oct 10, 2025
Bring Your Own Technology (BYOT) Playbook Offers Roadmap for Using Site-Based Tools in Pharma-Sponsored Trials
prnewswire ⢠Oct 07, 2025
FDAâs New Cell and Gene Therapy Guidances Finally Go a âClick Furtherâ to âGame Changingâ
biospace ⢠Oct 03, 2025
Medable to Present at Morgan Stanley Global Healthcare Conference
businesswire ⢠Oct 03, 2025
RegASK Appoints Deanna Coscia as Senior Vice President, Commercial
salestechstar ⢠Sep 23, 2025
Medable Management
Leadership team at Medable
Co-Founder & Chief Architect
James Sas
Co-Founder & CEO
Michelle Longmire
Join now and verify your accreditation status to gain access to:
- Medable Current Valuation
- Medable Stock Price
- Medable Management
- Available deals in Medable and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Medable Cap Table and Funding History by Share Class and Liquidity Preferences
- Medable Revenue and Financials
- Medable Highlights
- Medable Business Model
- Medable Risk Factors
- Medable Research Report from SACRA Research
Trading Medable Stock
How to invest in Medable stock?
Accredited investors can buy pre-IPO stock in companies like Medable through EquityZen funds. These investments are made available by existing Medable shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event â house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Medable stock?
Shareholders can sell their Medable stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
